MC
CELG

Muhlenkamp & Co’s Celgene Corp CELG Stock Holding History

Muhlenkamp & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,000
Closed -$313K – 73
2017
Q4 		$313K Hold
3,000
– – 0.09% 60
2017
Q3 		$437K Hold
3,000
– – 0.14% 52
2017
Q2 		$390K Hold
3,000
– – 0.12% 56
2017
Q1 		$373K Hold
3,000
– – 0.11% 60
2016
Q4 		$347K Hold
3,000
– – 0.11% 61
2016
Q3 		$314K Buy
+3,000
New +$325K 0.12% 47

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Muhlenkamp & Co's CELG Position: Q4 2019 in Review

Muhlenkamp & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 70,655 shares — an estimated $7.02M sold.

Muhlenkamp & Co first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $24.9M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Muhlenkamp & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Muhlenkamp & Co sold 70,655 Celgene Corp shares in Q4 2019, an estimated $7.02M.
  • Muhlenkamp & Co first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Muhlenkamp & Co's Celgene Corp position peaked at $24.9M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Muhlenkamp & Co's 13F filing for Q4 2019, filed 20 Feb 2020.